Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Narayana Hrudayalaya...

    Narayana Hrudayalaya former MD, CEO Ashutosh Raghuvanshi joins Fortis Healthcare as new CEO

    Farhat NasimWritten by Farhat Nasim Published On 2019-02-08T11:59:11+05:30  |  Updated On 17 Aug 2021 12:06 PM IST

    New Delhi: Ex-Managing Director(MD) and Group CEO of Narayana Hrudayalaya, Ashutosh Raghuvanshi has been appointed as the new Chief Executive Officer(CEO) of Fortis Healthcare effective from March 18, 2019. He will replace Bhavdeep Singh as the CEO of the company.


    Medical Dialogues had earlier reported that private sector hospital chain Narayana Hrudayalaya Ltd announced that Dr Ashutosh Raghuvanshi, Vice Chairman(VC), Managing Director(MD) and Group Chief Executive Officer(CEO) of Narayana Hrudayalaya Ltd (NH), had tendered his resignation from the services of the company.



    Dr Raghuvanshi decided to move on from NH on personal grounds, after serving the company for 18 years. Dr Raghuvanshi's resignation was deliberated by the Board of NH and stands accepted.


    Also Read: Narayana Hrudayalaya MD-Group CEO Ashutosh Raghuvanshi resigns



    Fortis Healthcare Thursday said it has appointed Ashutosh Raghuvanshi as the Chief Executive Officer of the company effective from March 18, 2019. He will replace Bhavdeep Singh as the CEO of the company.


    "Prior to joining Fortis, Dr Raghuvanshi was associated with the Narayana Hrudayalaya group for over 18 years. He was the Group Chief Executive Officer since November 19, 2010, Managing Director since November 3, 2011, and also served as its Executive Vice Chairman," Fortis Healthcare said in a statement.


    He was responsible for creating structures and processes to build a successful healthcare organisation, it added.

    "We are happy to welcome Dr Ashutosh Raghuvanshi as the newly appointed CEO of Fortis healthcare," IHH Healthcare MD and CEO and Fortis Board Member Tan See Leng said.

    With the healthcare industry in India witnessing a strategic paradigm shift in current times, Raghuvanshi's experience will be greatly valued in providing strategic direction and vision to the company and will ensure that its focus on clinical excellence, outcomes, patient centricity and business results remain paramount, he added.

    Fortis Chairman Ravi Rajagopal said that with a proven track record as a successful clinician and an able administrator, Raghuvanshi has developed a deep understanding of the business, patient care and healthcare sector.

    "His leadership at Fortis will be critical as the company continues to pursue its vision to create a world-class, integrated, healthcare delivery system," he added.

    Raghuvanshi is M.Ch in cardiothoracic surgery from Bombay Hospital Institute of Medical Sciences, MS (general surgery) and MBBS from Mahatma Gandhi Institute of Medical Sciences, Wardha, Nagpur University.
    Ashutosh RaghuvanshiFHLFortisFortis CEOFortis HealthcareFortis new CEOFortis VChospital chainshospital newsIHHIHH HealthcareIHH MDIndian HospitalNarayana Chief Operating OfficerNarayana group CEONarayana hospital newsNarayana HrudayalayaNarayana MDNarayana VC
    Source : With input

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok